Multiple Myeloma Clinical Trials in Atlanta

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
R
Recruiting
  • Multiple Myeloma
  • Miami, Florida
  • +14 more
2021-10-07
Oct 7, 2021
J
Active, not recruiting
  • Multiple Myeloma
  • Daratumumab IV
  • +3 more
  • Birmingham, Alabama
  • +211 more
2021-10-14
Oct 14, 2021
C
Terminated
  • B Cell Lymphomas
  • +3 more
  • ACTR T Cell Product
  • Gilbert, Arizona
  • +15 more
2021-10-04
Oct 4, 2021
J
Active, not recruiting
  • Multiple Myeloma
  • Daratumumab Subcutaneous (SC) Administration
  • Recombinant Human Hyaluronidase [rHuPH20]) SC Administration
  • Atlanta, Georgia
  • +11 more
2021-10-07
Oct 7, 2021
J
Active, not recruiting
  • Multiple Myeloma
  • Little Rock, Arkansas
  • +56 more
2021-10-07
Oct 7, 2021
J
Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +27 more
2021-10-07
Oct 7, 2021
P
Active, not recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +45 more
2021-10-06
Oct 6, 2021
G
Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • San Francisco, California
  • +5 more
2021-10-01
Oct 1, 2021
G
Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin frozen liquid
  • Belantamab mafodotin lyophilized powder
  • New Haven, Connecticut
  • +58 more
2021-09-30
Sep 30, 2021
N
Recruiting
  • Multiple Myeloma
  • +2 more
  • Goodyear, Arizona
  • +13 more
2021-09-30
Sep 30, 2021
K
Active, not recruiting
  • Multiple Myeloma
  • Plantation, Florida
  • +156 more
2021-09-24
Sep 24, 2021
S
Active, not recruiting
  • Multiple Myeloma
  • MMprofiler SKY92 gene signature
  • Washington, District of Columbia
  • +8 more
2021-09-23
Sep 23, 2021